Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1990 1
1991 1
1992 1
1993 1
1994 1
1995 2
1996 2
1997 1
1998 2
1999 4
2000 8
2001 3
2002 6
2003 5
2004 8
2005 9
2006 9
2007 11
2008 13
2009 14
2010 14
2011 12
2012 14
2013 18
2014 11
2015 32
2016 15
2017 33
2018 32
2019 22
2020 28
2021 26
2022 14
2023 18
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

363 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for line franck
Search for Linél Franck instead (2 results)
Romidepsin Plus CHOP Versus CHOP in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Results of the Ro-CHOP Phase III Study (Conducted by LYSA).
Bachy E, Camus V, Thieblemont C, Sibon D, Casasnovas RO, Ysebaert L, Damaj G, Guidez S, Pica GM, Kim WS, Lim ST, André M, García-Sancho AM, Penarrubia MJ, Staber PB, Trotman J, Hüttmann A, Stefoni V, Re A, Gaulard P, Delfau-Larue MH, de Leval L, Meignan M, Li J, Morschhauser F, Delarue R. Bachy E, et al. J Clin Oncol. 2022 Jan 20;40(3):242-251. doi: 10.1200/JCO.21.01815. Epub 2021 Nov 29. J Clin Oncol. 2022. PMID: 34843406 Clinical Trial.
Cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) therapy is widely used as first-line treatment of PTCL; however, it has limited efficacy. Results from a phase Ib and II study showed the feasibility of combining romidepsin with CHOP (Ro-CHOP). ...
Cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) therapy is widely used as first-line treatment of PTCL; however, it …
State-and-rate friction in contact-line dynamics.
Lindeman CW, Nagel SR. Lindeman CW, et al. Phys Rev E. 2023 Jun;107(6-2):065111. doi: 10.1103/PhysRevE.107.065111. Phys Rev E. 2023. PMID: 37464707
In order to probe the dynamics of contact-line motion, we study the macroscopic properties of sessile drops deposited on and then aspirated from carefully prepared horizontal surfaces. ...In this case, the damping coefficient decreases with increasing velocity of the conta …
In order to probe the dynamics of contact-line motion, we study the macroscopic properties of sessile drops deposited on and then asp …
First-line second generation tyrosine kinase inhibitors in patients with newly diagnosed accelerated phase chronic myeloid leukemia.
Balsat M, Alcazer V, Etienne G, Huguet F, Berger M, Cayssials E, Charbonnier A, Escoffre-Barbe M, Johnson-Ansah H, Legros L, Roy L, Delmer A, Ianotto JC, Orvain C, Larosa F, Meunier M, Amé S, Andreoli A, Cony-Makhoul P, Morisset S, Tigaud I, Rea D, Nicolini FE. Balsat M, et al. Leuk Res. 2023 Jul;130:107308. doi: 10.1016/j.leukres.2023.107308. Epub 2023 May 9. Leuk Res. 2023. PMID: 37230027
We hypothesize that off-license use of second generation TKI (TKI2) as front-line therapy might counterbalance this poor prognosis, with limited toxicity. In "real-life" conditions, newly diagnosed patients meeting the ELN cytological criteria for AP-CML or harboring ACA a …
We hypothesize that off-license use of second generation TKI (TKI2) as front-line therapy might counterbalance this poor prognosis, w …
Systematic compositional analysis of exosomal extracellular vesicles produced by cells undergoing apoptosis, necroptosis and ferroptosis.
Cappe B, Vadi M, Sack E, Wacheul L, Verstraeten B, Dufour S, Franck J, Xie W, Impens F, Hendrix A, Lafontaine DLJ, Vandenabeele P, Riquet FB. Cappe B, et al. J Extracell Vesicles. 2023 Oct;12(10):e12365. doi: 10.1002/jev2.12365. J Extracell Vesicles. 2023. PMID: 37807017 Free PMC article.
To this end, we performed a comparative analysis of steady-state (ssEVs) and cell death-associated EVs (cdEVs) following TNF-induced necroptosis (necEVs), anti-Fas-induced apoptosis (apoEVs), and ML162-induced ferroptosis (ferEVs) using the same cell line. For each RCD con …
To this end, we performed a comparative analysis of steady-state (ssEVs) and cell death-associated EVs (cdEVs) following TNF-induced necropt …
Immunomodulatory Agents in Follicular Lymphoma.
Ysebaert L, Morschhauser F. Ysebaert L, et al. Hematol Oncol Clin North Am. 2020 Aug;34(4):715-726. doi: 10.1016/j.hoc.2020.02.007. Epub 2020 Apr 8. Hematol Oncol Clin North Am. 2020. PMID: 32586576 Review.
This combination of lenalidomide with rituximab showed similar efficacy to chemoimmunotherapy (CIT) in first-line patients requiring therapy, and is approved in relapsed/refractory FL. ...
This combination of lenalidomide with rituximab showed similar efficacy to chemoimmunotherapy (CIT) in first-line patients requiring …
Final Results of the IELSG-19 Randomized Trial of Mucosa-Associated Lymphoid Tissue Lymphoma: Improved Event-Free and Progression-Free Survival With Rituximab Plus Chlorambucil Versus Either Chlorambucil or Rituximab Monotherapy.
Zucca E, Conconi A, Martinelli G, Bouabdallah R, Tucci A, Vitolo U, Martelli M, Pettengell R, Salles G, Sebban C, Guillermo AL, Pinotti G, Devizzi L, Morschhauser F, Tilly H, Torri V, Hohaus S, Ferreri AJM, Zachée P, Bosly A, Haioun C, Stelitano C, Bellei M, Ponzoni M, Moreau A, Jack A, Campo E, Mazzucchelli L, Cavalli F, Johnson P, Thieblemont C. Zucca E, et al. J Clin Oncol. 2017 Jun 10;35(17):1905-1912. doi: 10.1200/JCO.2016.70.6994. Epub 2017 Mar 29. J Clin Oncol. 2017. PMID: 28355112 Free article. Clinical Trial.
The IELSG-19 phase III study, to our knowledge, was the first such study to address the question of first-line treatment in a randomized trial. Patients and Methods Eligible patients were initially randomly assigned (1:1 ratio) to receive either chlorambucil monotherapy (6 …
The IELSG-19 phase III study, to our knowledge, was the first such study to address the question of first-line treatment in a randomi …
Protocolized sedation vs usual care in pediatric patients mechanically ventilated for acute respiratory failure: a randomized clinical trial.
Curley MA, Wypij D, Watson RS, Grant MJ, Asaro LA, Cheifetz IM, Dodson BL, Franck LS, Gedeit RG, Angus DC, Matthay MA; RESTORE Study Investigators and the Pediatric Acute Lung Injury and Sepsis Investigators Network. Curley MA, et al. JAMA. 2015 Jan 27;313(4):379-89. doi: 10.1001/jama.2014.18399. JAMA. 2015. PMID: 25602358 Free PMC article. Clinical Trial.
Sedation-related adverse events including inadequate pain and sedation management, clinically significant iatrogenic withdrawal, and unplanned endotracheal tube/invasive line removal were not significantly different between the 2 groups. ...
Sedation-related adverse events including inadequate pain and sedation management, clinically significant iatrogenic withdrawal, and unplann …
Franck-Condon and Herzberg-Teller Signatures in Molecular Absorption and Emission Spectra.
Kundu S, Roy PP, Fleming GR, Makri N. Kundu S, et al. J Phys Chem B. 2022 Apr 21;126(15):2899-2911. doi: 10.1021/acs.jpcb.2c00846. Epub 2022 Apr 7. J Phys Chem B. 2022. PMID: 35389662
Some molecules of chemical and biological significance possess vibrations with significant Herzberg-Teller (HT) couplings, which render the Franck-Condon (FC) approximation inadequate and cause the breakdown of the well-known mirror-image symmetry between linear absorption …
Some molecules of chemical and biological significance possess vibrations with significant Herzberg-Teller (HT) couplings, which render the …
Immuno-regulatory malignant B cells contribute to Chronic Lymphocytic Leukemia progression.
Mékinian A, Quinquenel A, Belkacem KA, Kanoun F, Dondi E, Franck E, Boubaya M, Mhibik M, Baran-Marszak F, Letestu R, Ajchenbaum-Cymbalista F, Lévy V, Varin-Blank N, Le Roy C. Mékinian A, et al. Cancer Gene Ther. 2023 Jul;30(7):1018-1028. doi: 10.1038/s41417-023-00602-5. Epub 2023 Mar 28. Cancer Gene Ther. 2023. PMID: 36973425 Free PMC article.
Neutralizing secreted IL10 or inhibiting the TGFbeta signalling pathway demonstrated that these cytokines are mainly involved in Th- and Treg differentiation/maintenance. In line with the regulatory subsets, we also demonstrated that a CLL B cell population expresses FOXP3 …
Neutralizing secreted IL10 or inhibiting the TGFbeta signalling pathway demonstrated that these cytokines are mainly involved in Th- and Tre …
Beau's line in COVID-19 after a long ICU stay.
Paula JA, Franck CL, Justino SR, Leite LS, Ramos Junior O, Rabito EI. Paula JA, et al. Nutr Hosp. 2022 Aug 25;39(4):945-948. doi: 10.20960/nh.04131. Nutr Hosp. 2022. PMID: 35815764 Free article. English.
363 results